Experience with sotrovimab treatment of SARS‐CoV‐2‐infected patients in Denmark

AIMS: To evaluate the experience with use of sotrovimab following severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in high‐risk groups. METHODS: In a nationwide, population‐based cohort study, we identified all individuals treated with sotrovimab (N = 2933) and stratified them...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Line Dahlerup, Lebech, Anne‐Mette, Øvrehus, Anne, Poulsen, Birgitte Klindt, Christensen, Hanne Rolighed, Nielsen, Henrik, Johansen, Isik Somuncu, Omland, Lars Haukali, Wiese, Lothar, Helleberg, Marie, Storgaard, Merete, Dalager‐Pedersen, Michael, Rasmussen, Thomas A., Benfield, Thomas, Petersen, Tonny Studsgaard, Andersen, Åse Bengård, Gram, Mie Agermose, Stegger, Marc, Edslev, Sofie Marie, Obel, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878138/
https://www.ncbi.nlm.nih.gov/pubmed/36519217
http://dx.doi.org/10.1111/bcp.15644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878138/
https://www.ncbi.nlm.nih.gov/pubmed/36519217
http://dx.doi.org/10.1111/bcp.15644

Ejemplares similares